HomeAuthorsPosts by admin

admin

1868 POSTS6 COMMENTS

Latest Pharma-News

AstraZeneca and Daiichi Sankyo’s Enhertu met prespecified criteria for objective response rate and duration of response

admin - March 6, 2023 0

Latest Pharma-News

FDA Outlines Steps to Strengthen Tobacco Program

admin - February 27, 2023 0

Latest Pharma-News

AZ’s acquisition with CinCor Pharma completed

admin - February 27, 2023 0

Latest Pharma-News

Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance

admin - February 23, 2023 0

Latest Pharma-News

FDA Provides Draft Labeling Recommendations for Plant-based Milk Alternatives to Inform Consumers

admin - February 23, 2023 0

Latest Pharma-News

FDA Files Civil Money Penalty Complaints Against Four E-Cigarette Product Manufacturers

admin - February 23, 2023 0

Latest Pharma-News

Pediatric research at ReSViNET 2023 underscores Beyfortus’ potential to prevent RSV disease in infants

admin - February 23, 2023 0

Latest Pharma-News

AZ enters license agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate

admin - February 23, 2023 0

Latest Pharma-News

ReSViNet 2023 data reinforce AZ’s commitment to help prevent Respiratory Syncytial Virus in infants

admin - February 21, 2023 0

Latest Pharma-News

Opdivo® with CABOMETYX® Shows Durable Survival with Over Three Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma

admin - February 15, 2023 0

Latest Pharma-News

Bayer completes acquisition of Blackford Analysis Ltd.

admin - February 15, 2023 0

Latest Pharma-News

Sanofi announces change in R&D leadership

admin - February 15, 2023 0

1...678...156 Page 7 of 156

TOP AUTHORS

admin

1868 POSTS6 COMMENTS

OIdMIHuOdiu

0 POSTS0 COMMENTS

tintin

0 POSTS0 COMMENTS

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

February 10, 2025

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

February 3, 2025

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

February 3, 2025

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

January 24, 2025

admin

TOP AUTHORS

Most Read

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Interview Questions on Institutional Review Board(IRB)

POPULAR POSTS

How to Find Paid Clinical Trials Near You

What Is CDISC and What Are CDISC Data Standards?

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

POPULAR CATEGORY

ABOUT US

FOLLOW US